Wordt geladen...
Targeting Molecular Aberrations in Urothelial Carcinoma: Are We Almost There?
Advances in tumor biology and cancer genetics have led to the development of effective targeted therapies in oncology over the past decade. However, targeted drug development for urothelial carcinoma has been slower than for some other malignancies. The path forward in drug development is through a...
Bewaard in:
| Gepubliceerd in: | Am Soc Clin Oncol Educ Book |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776417/ https://ncbi.nlm.nih.gov/pubmed/23714499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EdBook_AM.2013.33.195 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|